NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
Clinical trial condition
CD20+ Lymphoblastic Lymphoma
Explore clinical trials studying CD20+ Lymphoblastic Lymphoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study